Clinical Trials
117 trialsARC-25
Arcus Biosciences, Inc.
KYOCOL
Institut du Cancer de Montpellier - Val d'Aurelle
CATPCC-01
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Embrace Gyn
Medtronic - MITG
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
National Cancer Institute (NCI)
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
National Cancer Institute (NCI)
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer
National Cancer Institute (NCI)
TroFuse-020
Merck Sharp & Dohme LLC
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Alterome Therapeutics, Inc.
HYPOCx-iRex
Siriraj Hospital
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
M.D. Anderson Cancer Center
EXCEED
Eli Lilly and Company
PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
M.D. Anderson Cancer Center
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
National Institutes of Health Clinical Center (CC)
Education and Health in Women With Cervical Cancer
Federal University of Maranhao
Stereotactic Body Radiotherapy Boost Versus Simultaneous Integrated Boost to Pelvic Nodes Among Patients Receiving Radical Chemoradiation in Carcinoma Cervix
All India Institute of Medical Sciences
SHIP-A-S01
National Cancer Institute (NCI)
LMI-001-A-S03
National Cancer Institute (NCI)
LMI-001-A-S02
National Cancer Institute (NCI)
MK-2870-001
Klus Pharma Inc.
Cervix Hypoxia FAZA
University Health Network, Toronto
JCDATAZONEWH
The University of Hong Kong
Primary HPV-based Cervical Cancer Screening Algorithms in Botswana
Beth Israel Deaconess Medical Center
Compass
VCS Foundation
MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
M.D. Anderson Cancer Center
Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR
M.D. Anderson Cancer Center
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
National Institutes of Health Clinical Center (CC)
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
PRESERVE-009
OncoC4, Inc.
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation
International Agency for Research on Cancer
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
H. Lee Moffitt Cancer Center and Research Institute
Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)
H. Lee Moffitt Cancer Center and Research Institute
GC-BIO
Institut Paoli-Calmettes
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Taiho Oncology, Inc.
CATSystem
University of Kansas Medical Center
Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer
M.D. Anderson Cancer Center
Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer
Sun Yat-sen University
Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels
University Health Network, Toronto
Predictive Assays In Cervix Cancer
University Health Network, Toronto
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
Duke University
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix
M.D. Anderson Cancer Center
IL Believe
Ascendis Pharma A/S
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors
Qurient Co., Ltd.
ATARI
Institute of Cancer Research, United Kingdom
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
AbbVie
PETRA
AstraZeneca
ESSAG
University Ghent